tadalafil has been researched along with Carcinoma, Epidermoid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreher, K; Newton, E; Valdes-Rodriguez, R | 1 |
| Borrello, I; Califano, J; De la Fuente, AC; Gomez, C; Nazarian, R; Reis, IM; Sargi, Z; Serafini, P; Vella, JL; Weed, DT | 1 |
| Agrawal, N; Blanco, R; Borrello, I; Califano, JA; Fakhry, C; Goodman, S; Gourin, CG; Ha, PK; Khan, Z; Koch, WM; Levine, M; Marur, S; Neuner, G; Noonan, KA; Richmon, JD; Rudraraju, L; Saunders, J; Serafini, P; Tang, M; Wang, H; Weed, DT; Zhang, Z | 1 |
| Ben-Jonathan, N; Fox, SR; Mierzwa, ML; Tuttle, TR; Wells, SI | 1 |
2 trial(s) available for tadalafil and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carbolines; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Head and Neck Neoplasms; Humans; Immunity; Male; Middle Aged; Myeloid Cells; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes, Regulatory; Tadalafil | 2015 |
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carbolines; Carcinoma, Squamous Cell; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Head and Neck Neoplasms; Humans; Immunity, Cellular; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes; Tadalafil | 2015 |
2 other study(ies) available for tadalafil and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Tadalafil as a Risk Factor for Excessive Intra-operative Bleeding During Dermatologic Surgery.
Topics: Blood Loss, Surgical; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Intraoperative Period; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Risk Factors; Tadalafil; Thorax | 2021 |
The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Female; Guanylate Cyclase; Head and Neck Neoplasms; Humans; Mice; Phosphodiesterase 5 Inhibitors; Pyrazoles; Pyridines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tadalafil | 2016 |